Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond

scientific article published on February 2011

Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BEEM.2010.06.008
P698PubMed publication ID21396578
P5875ResearchGate publication ID50374784

P2093author name stringKyriaki S Alatzoglou
Mehul T Dattani
Mark James McCabe
P433issue1
P921main subjectsepto-optic dysplasiaQ2756703
P304page(s)115-124
P577publication date2011-02-01
P1433published inBest Practice and Research: Clinical Endocrinology and MetabolismQ15755890
P1476titleSepto-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond
P478volume25

Reverse relations

cites work (P2860)
Q52092392A heterozygous microdeletion of 20p12.2-3 encompassing PROKR2 and BMP2 in a patient with congenital hypopituitarism and growth hormone deficiency.
Q36122441ATOH7 mutations cause autosomal recessive persistent hyperplasia of the primary vitreous
Q90413351Antenatal diagnosis of absence of septum pellucidum
Q39332895Central hypothyroidism - a neglected thyroid disorder
Q37736165Characterization of a novel HESX1 mutation in a pediatric case of septo-optic dysplasia.
Q36366089Clinical and Radiologic Spectrum of Septo-optic Dysplasia: Review of 17 Cases
Q42281635Clinical characteristics of septo-optic dysplasia accompanied by congenital central hypothyroidism in Japan
Q38868271Combined pituitary hormone deficiency due to gross deletions in the POU1F1 (PIT-1) and PROP1 genes.
Q61795789Compensatory growth renders Tcf7l1a dispensable for eye formation despite its requirement in eye field specification
Q28082907Congenital anomalies of the optic nerve
Q36807457Deletion of OTX2 in neural ectoderm delays anterior pituitary development
Q52140982Development of the Neuroendocrine Hypothalamus.
Q57642468Editors’ Introduction
Q36100642Genetic Overlap between Holoprosencephaly and Kallmann Syndrome.
Q35869509Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia
Q38797075Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.
Q35899337Genomic imbalances detected by array-CGH in patients with syndromal ocular developmental anomalies
Q52652594Growth hormone - past, present and future.
Q53775457Hyperphagia, mild developmental delay but apparently no structural brain anomalies in a boy without SOX3 expression.
Q50421935Increasing incidence of optic nerve hypoplasia/septo-optic dysplasia spectrum: Geographic clustering in Northern Canada.
Q50668102Midbrain-hindbrain involvement in septo-optic dysplasia.
Q50063427Nervous System Malformations
Q36284895Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD).
Q37964618Phenotype-genotype correlations in congenital isolated growth hormone deficiency (IGHD).
Q89540328Pituitary abnormalities in midline brain defects
Q37427898Prenatal determinants of optic nerve hypoplasia: review of suggested correlates and future focus
Q34546986Prenatal ethanol exposure in mice phenocopies Cdon mutation by impeding Shh function in the etiology of optic nerve hypoplasia
Q37723287Rare Frequency of Mutations in Pituitary Transcription Factor Genes in Combined Pituitary Hormone or Isolated Growth Hormone Deficiencies in Korea
Q45867173Reply: To PMID 23460194.
Q58697169Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes
Q36624356Septo-Optic Dysplasia in a Newborn Presenting with Bilateral Dilated and Fixed Pupils
Q91875312Septo-optic Dysplasia Plus Syndrome
Q92992906Septo-optic dysplasia caused by a novel FLNA splice site mutation: a case report
Q47219506Septo-optic dysplasia in childhood: the neurological, cognitive and neuro-ophthalmological perspective
Q46539892Six adult patients with septo-optic dysplasia and drug-resistant epilepsy: Clinical findings and course
Q30933908Spectrum of clinical presentations and endocrinological findings of patients with septo-optic dysplasia: a retrospective study
Q41879212Structural pituitary abnormalities associated with CHARGE syndrome.
Q36563310Transcription factor 7-like 1 is involved in hypothalamo-pituitary axis development in mice and humans
Q37613192Vascular cerebral anomalies associated with Septo-Optic Dysplasia. A case report
Q89629071Whole genome sequencing unveils genetic heterogeneity in optic nerve hypoplasia

Search more.